Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23,
Boston Convention and Exhibition Center

THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS

Access novel science, technologies and contacts to improve efficiencies across the entire spectrum of biopharmaceutical development and production

Download Full Agenda Register by July 30 Save $600

Learn from the brightest minds in bioprocessing

Each year, BPI's scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Below are some of the key speakers who are confirmed to present as part of BPI 2021.

Katalin Karikó, PhD

Senior Vice President RNA Protein Replacement Therapy

BioNTech

Charles Sardonini, PhD

Head, Drug Substance Manufacturing for Biologics – Upstream Processing

Sanofi

John Maraganore, PhD

Chief Executive Officer

Alnylam Pharmaceuticals, Inc

Hao Chen, PhD

Head of Cell & Viral Drug Substance

GSK Vaccines

Hanne Bak, Ph.D.

Senior Vice President, Pre-clinical Manufacturing & Process Development

Regeneron Pharmaceutical, Inc.

Natraj Ram, Ph.D.

Senior Director, Vaccine Process Development

Takeda

Roy Sorek

Director, Quality Assurance

bluebird bio

Julia Ding, PhD

Head, Global Process Analytics

Bristol Myers Squibb

Meet the BPI 2021 Speakers

Get the latest event updates

Access Novel Science Across the Entire Bioprocessing Spectrum

Our BPI 2021 agenda includes 9 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Your registration provides access to the presentations across all 9 tracks, allowing you to create an agenda tailored specifically for your needs.

Manufacturing Strategy & Bioprocessing 4.0

Apply digital technologies, artificial intelligence and machine learning to increase manufacturing efficiency through smart and data-driven bioprocessing.

Cell Culture & Upstream Processing

Optimize speed, titers, efficiency and quality in upstream process development.

Recovery & Purification

Apply novel technologies that are enabling next generation downstream processes to overcome bottlenecks and optimize manufacturing, quality and control of emerging modalities.

Analytical & Quality

Achieve a high quality product using optimal analytical strategies while reducing timelines.

Intensified & Continuous Processing

Accelerate manufacturing timelines by achieving intensified and fully continuous processing from the development, optimization and implementation of novel technologies, analytical tools and automated systems.

Speed from Gene to Market

Gain the industry insights you need to accelerate speed and compress timelines to IND and BLA submissions.

Cell Therapy

Build your analytical toolbox to improve testing, characterization & validation strategies

Gene Edited Ex Vivo Cell Therapy

Overcome autologous and allogeneic manufacturing challenges with novel modalities, gene editing and more

In Vivo Gene Therapy

Learn about next generation cells lines, production optimization & novel platforms

See the full agenda

Lars Pampel, Ph.D., Head, Process Sciences, Technical Development, New Biological Entities, Novartis, Switzerland

DataHow

“BPI brings leading thoughts and discussion to a balanced audience of scientists and decision makers.”

CONNECT WITH KEY BUYERS BY BECOMING A BPI SPONSOR/EXHIBITOR

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals in today's virtual environment.

(Companies A-L) Contact Jennifer Wickett: Jennifer.Wickett@informa.com | +1-857-504-6694

(Companies M-Z) Contact Blake Shuka: Blake.Shuka@informa.com | +1-857-504-6684

DOWNLOAD SPONSOR PROSPECTUS

Early Registration Savings Deadline Expires In